Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when JHX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: JHX James Hardie Industries plc 8-K

James Hardie sells European Fermacell business to Holcim for €840M, to close fiber cement ops

Filed August 20, 2026 · Period ending August 20, 2026 · ~1 min read

5 key changes 4 high relevance 3 sections

Key Changes

  • high

    Agreed to sell European fibre gypsum and cement-bonded products business (Fermacell) to Holcim for €840M (~$980M USD) cash, subject to net debt and working capital adjustments; expected to close H1 2027 pending antitrust approvals and employee consultations.

    Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
  • high

    Plans to use ~$600M of proceeds to repay debt, accelerating progress toward net leverage target below 2.0x by September 30, 2027; transaction expected to be accretive to margin profile and return on invested capital.

    Exhibit 99.1 view on EDGAR →
  • high

    Intends to close European fiber cement business entirely (separate from Fermacell sale), subject to legal, regulatory, and employee consultation requirements; represents full exit from European operations.

    Exhibit 99.1 view on EDGAR →
  • high

    Board authorized new $250M share repurchase program with flexible execution methods including open market purchases, private transactions, and accelerated repurchase programs; timing and amount at management discretion.

    Item 7.01 — Regulation FD Disclosure verify on EDGAR →
  • medium

    Holcim may owe €15M termination fee (~1.8% of deal value) under specified circumstances if transaction fails; Holcim to obtain warranty and indemnity insurance, limiting JHX post-closing liability exposure.

    Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →

Summary

James Hardie is executing a significant portfolio rationalization, exiting European operations entirely through a two-part strategy: selling its Fermacell fibre gypsum and cement-bonded products business to Holcim for €840 million (~$980 million USD) and closing its European fiber cement operations.

The Fermacell sale, expected to close in the first half of 2027 pending regulatory approvals, represents a clean exit from non-core product lines while the fiber cement closure completes the European withdrawal. Management characterized the moves as refocusing on "highest growth and return opportunities" in core regions. The financial deployment is balanced between deleveraging and shareholder returns.

Approximately $600 million of the sale proceeds will repay debt, accelerating the company's path to its stated net leverage target below 2.0x by September 30, 2027. Concurrently, the Board authorized a new $250 million share repurchase program with flexible execution methods. The transaction is expected to be accretive to margin profile and return on invested capital, suggesting the divested European operations were dilutive to consolidated performance. The deal includes a €15 million termination fee payable by Holcim under certain circumstances and limits James Hardie's post-closing liability through warranty and indemnity insurance, providing downside protection if the transaction fails and a cleaner exit if it closes.

Section-by-Section Diff

Event · Item 1.01 — Entry into a Material Definitive Agreement

~400 words

Item 1.01 — Entry into a Material Definitive Agreement filed; see Key Changes for terms.

3 Added
Added European business divestiture high

Added in current filing · verify on EDGAR →

the Sellers agreed to sell to the Purchaser, and the Purchaser agreed to purchase from the Sellers, all of the issued and outstanding equity interests of certain subsidiaries comprising the Company's European fibre gypsum and cement-bonded products business for a purchase price of €840 million, subject to customary adjustments for net debt and working capital as of closing

James Hardie entered into a definitive agreement to sell its European fibre gypsum and cement-bonded products business to Holcim for €840 million, subject to net debt and working capital adjustments. The transaction excludes the company's European fiber cement operations, which will be wound down prior to closing. This represents a significant portfolio rationalization, allowing James Hardie to exit non-core European product lines while retaining its fiber cement business elsewhere.

Added Transaction timing and conditions medium

Added in current filing · verify on EDGAR →

Completion of the Transaction is subject to customary closing conditions, including receipt of required antitrust approvals and completion of employee consultation processes where required, and is expected to occur in the first half of calendar year 2027.

The sale is expected to close in the first half of 2027, pending antitrust approvals and employee consultation processes. The extended timeline reflects the regulatory review required for a cross-border transaction of this size. Investors should note the deal is not yet certain and faces standard regulatory hurdles.

Added Seller liability limitations medium

Added in current filing · verify on EDGAR →

The Purchaser has agreed to obtain warranty and indemnity insurance, and the Purchase Agreement generally limits post-closing recourse against the Sellers.

Holcim will obtain warranty and indemnity insurance, and the agreement limits James Hardie's post-closing liability exposure. This structure is favorable to the seller, reducing potential future claims and providing a cleaner exit from the divested business.

Event · Item 7.01 — Regulation FD Disclosure

~200 words

Item 7.01 — Regulation FD Disclosure filed; see Key Changes for terms.

1 Added
Added Share repurchase authorization high

Added in current filing · verify on EDGAR →

the Company also announced that its Board of Directors has authorized a share repurchase program of up to $250 million USD. Under the repurchase program, the Company may purchase its shares from time to time through open market repurchases, privately negotiated transactions or other means, including accelerated share repurchase programs or through the use of other techniques.

The Board authorized a new share repurchase program allowing the company to buy back up to $250 million of its ordinary shares. The program provides flexibility in execution methods including open market purchases, private transactions, and accelerated repurchase programs. The timing and amount of actual repurchases will depend on market conditions and other factors, and the company is not obligated to repurchase any shares.

Event · Exhibit 99.1

James Hardie sells European Fermacell business to Holcim for €840M, plans to close European fiber cement ops, and authorizes $250M buyback.

3 Added
Added Sale of Fermacell to Holcim high

Added in current filing · view on EDGAR →

The Company has entered into an agreement to sell its sustainable walling and flooring solutions business Fermacell in Europe, including the fermacell® and Aestuver® brands, to Holcim (SIX: HOLN), a global provider of high-value end-to-end building materials and solutions based in Switzerland, for €840 million, or currently approximately $980 million USD, in cash.

James Hardie is selling its Fermacell business in Europe to Holcim for €840 million (approximately $980 million USD) in cash. The transaction is expected to close in the first half of calendar 2027, subject to regulatory approvals and employee consultation processes. The company plans to use approximately $600 million of the proceeds to repay debt, accelerating progress toward its net leverage target below 2.0x by September 30, 2027.

Added $250 million share repurchase authorization high

Added in current filing · view on EDGAR →

In addition, James Hardie’s Board of Directors has authorized a new $250 million share repurchase program. Repurchases may be effected through open-market purchases, accelerated share repurchases or other methods as determined by the Company, subject to market conditions and other relevant considerations.

The Board has authorized a new $250 million share repurchase program. Repurchases may be executed through open-market purchases, accelerated share repurchases, or other methods, subject to market conditions. This represents a capital return initiative alongside the debt repayment plan funded by the Fermacell sale proceeds.

Added Strategic rationale and portfolio realignment medium

Added in current filing · view on EDGAR →

The strategic divestiture of our European operations and the intended closure of the European fiber cement business will enable us to focus on our highest growth and return opportunities

CEO Aaron Erter stated that divesting European operations will enable the company to focus on its highest growth and return opportunities. The actions are intended to strengthen the balance sheet, deliver value for shareholders, and align the portfolio with the company's long-term growth strategy in core regions.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 21, 2026 · How we verify